Ivana von Metzler

5PUBLICATIONS
55CO-AUTHORS
Medical mycologyInnate immunityMolecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|Nov 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma.

Khalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei

|Jan 06, 2023
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.

Nicola Giesen, Manik Chatterjee, Christof Scheid

|Oct 17, 2021
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma.

Julius C Enßle, Julia Campe, Amelie Schwenger

|Apr 03, 2021
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.

Friederike Bachmann, Martin Schreder, Monika Engelhardt

Pageof 1

Frequent Collaborators

2 joint publications

Carsten Müller-Tidow

2 joint publications

Hartmut Goldschmidt

2 joint publications

Marc S Raab

1 joint publications

Nicola Giesen